Clinical Trial

The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold Intervention

Recruiting
View on ClinicalTrials.gov →
Summary
The main aim of this study is to assess the effect of a chewing gum containing galactooligosaccharides (GOS) on the body mass index (BMI), the metabolism and the oral and intestinal microbiomes in a population of overweight adults.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-16; most recent amendment 2025-11-17.
Status change: Not Yet Recruiting → Recruiting 2025-11-17
Trial Details
NCT Number NCT07036692
Lead Sponsor University of Bern
Collaborators: DCB Research AG
Conditions Nutritional and Metabolic Diseases, Overweight
Enrollment 120 participants
Start Date 2025-10-09
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-21